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ABSTRACT
Introduction After first stroke, the transition from
rehabilitation to home can be confronting and fraught with
challenges. Although stroke clinical practice guidelines
recommend predischarge occupational therapy home
visits to ensure safe discharge and provision of appropriate
equipment, there is currently limited evidence to support
this recommendation.
Methods and analysis The HOME Rehab trial is a
national, multicentre, phase III randomised controlled
trial with concealed allocation, blinded assessment and
intention-to-treat analysis being conducted in Australia.
The trial aim is to determine the effect and potential
cost-effectiveness of an enhanced occupational therapy
discharge planning intervention that involves pre and
postdischarge home visits, goal setting and occupational
therapy in the home (the HOME programme) in comparison
to an in-hospital predischarge planning intervention. Stroke
survivors aged ≥45 years, admitted to a rehabilitation
ward, expected to return to a community (private) dwelling
after discharge, with no significant prestroke disability
will be randomly allocated 1:1 to receive a standardised
discharge planning intervention and the HOME programme
or the standardised discharge planning intervention alone.
The primary outcome is participation measured using the
Nottingham Extended Activities of Daily Living. Secondary
outcome areas include hospital readmission, disability,
performance of instrumental activities of daily living,
health-related quality of life, quality of care transition and
carer burden. Resources used/costs will be collected for
the cost-effectiveness analysis and hospital readmission.
Recruitment commenced in 2019. Allowing for potential
attrition, 360 participants will be recruited to detect a
clinically important treatment difference with 80% power
at a two-tailed significance level of 0.05.
Ethics and dissemination This study is approved by
the Alfred Health Human Research Ethics Committee
and site-specific ethics approval has been obtained at
all participating sites. Results of the main trial and the
secondary endpoint of cost-effectiveness will be submitted
for publication in peer-reviewed journals
Trial registration number
ACTRN12618001360202

Strengths and limitations of this study
►► The HOME Rehab trial will be conducted as a pow-

ered randomised controlled trial to measure the
effect of adding an enhanced occupational therapy
discharge planning intervention; it will provide clinicians and hospital administrators with important
information about supporting people with stroke to
transition from hospital to home.
►► This is a phase III trial with concealed allocation,
blinded assessment and intention-to-treat analysis
and includes a process evaluation and economic
evaluation.
►► The trial will be adequately powered to detect a clinically important treatment difference in functional
independence at 4-week postdischarge from hospital after first stroke.
►► Owing to the type of interventions, blinding of the
participants and treatment providers is not possible.

INTRODUCTION
Transitioning to home from hospital is
a critical time for people poststroke.1–3
Hospital-
community communication and
coordination can be inadequate during the
discharge phase,4–6 increasing the risk of poor
return to community activity, low satisfaction,
adverse events and unplanned readmission.
The most effective method for supporting
hospitalised people who have experienced
stroke to transition from hospital to home is
not yet known7 8 which has led to variability in
practice within the rehabilitation context.9 10
As a rehabilitation programme draws close
to discharge, it is usual for people with stroke
to be involved in discharge planning where
they receive an occupational therapy predischarge home assessment. While it is recommended in national clinical guidelines that
occupational therapy predischarge home
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visits occur ‘to ensure safety and provision of appropriate
aids, support and community services’,11 research to date
suggests that there may not be any difference in outcomes
for people who do and do not receive predischarge
occupational therapy home visits.12–16 What remains
unknown is whether a comprehensive discharge support
programme that crosses the boundaries between hospital
inpatient and community outpatient services may be
more beneficial than usual care, which may lack coordination and effective communication. Therefore, we have
designed the HOME Rehab trial to address this research
gap.
The aim of this phase III randomised trial is to determine the clinical effect (disability, participation, instrumental activities of daily living), change in the number
of unplanned readmissions and the potential cost-
effectiveness of an enhanced occupational therapy
discharge planning intervention that involves pre and
postdischarge home visits, goal setting and occupational
therapy in the home (the HOME programme) in comparison to an in-hospital predischarge planning intervention.
The specific research questions are:
1. In survivors of stroke, does the addition of the HOME
programme to an in-hospital predischarge planning
intervention improve activity participation at 4-week
postdischarge (primary aim)?
2. Does it reduce unplanned hospital readmissions (secondary aim)?
3. Is it cost-effective (secondary aim)?
weeks postdisPrimary end point is assessed at 4-
charge; secondary aims, clinical outcomes and health
month and 12-
months
economics are assessed at 6-
postdischarge.

METHOD AND ANALYSIS
Design
The HOME Rehab trial is a multicentre, phase III
randomised controlled trial being conducted in
Australia with concealed allocation, blinded measurement and intention-
to-
treat analysis. Adults who have
experienced stroke will be recruited from inpatient rehabilitation wards across multiple states in Australia; the
list of sites is available on the trial registry. Participants
will be randomly allocated to receive in-hospital predischarge planning and the HOME programme or in-hospital discharge planning alone. Clinical outcomes will be
measured at baseline, 1-month (4-weeks) postdischarge
(end of intervention) and 6 months postdischarge
(beyond the intervention); health economic outcomes
will be measured at 6 and 12 months postdischarge
(figure 1). Measurements will be collected by assessors
blind to group allocation. It is not possible to blind participants or therapists to group allocation. The protocol has
been approved by the relevant Human Research Ethics
Committees and is registered at www.
ANZCTR.
org.
au
(ACTRN12618001360202).
2

Figure 1

Design of the trial.

Participants, therapists, sites
People with stroke will be included if they are aged
≥45 years; admitted to a rehabilitation ward, which
includes referral for occupational therapy; expected to
return to live in a community (private) dwelling after
discharge from hospital and have no significant prestroke
disability (prestroke-modified Rankin Scale (mRS) score
0–2). Participants will be excluded if they need major
home modifications or receive daily assistance with all
care so as to enable discharge, have severe comorbid
disease (as assessed by a score <8 on the Charlson Comorbidity Index), have an illness likely to be associated with
a life expectancy of <12 months, have a significant cognitive impairment (>5 adjusted errors on the Short Portable
Mental Status Questionnaire), have a body mass index of
45 or higher, have moderate or severe aphasia or have a
planned discharge to an address 2 hours or greater from
a recruiting site.
Therapists will be eligible to deliver the intervention
if they are occupational therapists with ≥3 years of experience and have completed training in the standardised
delivery of the HOME programme.
Rehabilitation wards will be included if they have a
stroke throughput of ≥20/year.
Randomisation and blinding procedure
Assessors will be blinded to treatment allocation. Participants will be randomly allocated to one of the two groups
using a fixed allocation ratio of 1:1 following consent
and baseline assessment. We anticipate that the response
to both discharge programmes may be associated with
pretreatment motor ability and whether their inpatient
occupational therapist conducts the postdischarge visits,
and so participants will be stratified by baseline Functional
Lannin NA, et al. BMJ Open 2021;11:e044573. doi:10.1136/bmjopen-2020-044573
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Independence Measure (FIM)17 motor score (≤38 vs >38)
and mode of delivery of occupational therapy (inpatient
therapist vs community therapist) to minimise group
imbalances on these variables. To maintain sequential
recruitment balance between groups throughout the
trial, a permuted block randomisation process will be
used within each strata using random block sizes. The
randomisation creation process (including block sizes)
and resulting schedule will be set, held and managed
centrally external to the investigators (LCh, The University of Melbourne) and will be managed using Research
Electronic Data Capture (REDCap).18 19

Box 1 Clinical aims of the HOME occupational therapy
programme
Prepare the person to return home and resume their desired
lifestyle
►► Assess the individual person’s occupational needs respecting their
personal beliefs, needs and goals and understand the older person’s
patterns of daily living.27 42
►► Recommend functional adaptations that will maximise the person’s
abilities as they reintegrate back to usual living.43
44
►► Optimise the person-environment fit.
►► Recommend and implement environmental modifications.
42
►► Prescribe adaptive equipment and observe its use in situ.
►► Facilitate effective communication between the individual person
and their General Practitioner (GP) / health partners to support the
transfer of medical information from hospital to community.28
Enhance self-
efficacy beliefs and promote independence and
sense of control through mastery of meaningful tasks
►► Transfer altered skills to the home situation and assist in the adjustment to these changes.45
►► Habitual retraining in situ using strategies such as situational cues
and targeting behaviours for change.
►► Encourage one-on-one education about the safe performance of activities in and around their home and immediate community.
42 45
►► Facilitate joint problem-solving and solution generation.
46
►► Lessen a person’s fear during the transition from hospital to home.
Use goal setting and motivational interviewing as therapeutic tools
►► Develop client-centred goals that address individual occupational
needs.27 42
►► Develop goals that aim to maximise the person’s potential to participate in meaningful activities.43
►► Include goals that enable the person to participate in activities both
in the home and in the community42 and incorporate primary health
and physical activity goals.
►► Plan for increasing independence/capacity postdischarge, setting
goals for increasing activity.45 47

Intervention
Participants in both groups (control and experimental)
will undergo a standardised predischarge planning
intervention led by an occupational therapist, and the
experimental group will additionally receive the HOME
programme.
This standardised in-
hospital predischarge planning
intervention will include one 30 minute in-
hospital
discharge planning assessment using the Discharge Planning Assessment Tool (DPAT)20 and a family-led home
environment assessment. The DPAT is a client-centred
assessment to prepare for discharge to a home environment; DPAT is to be completed by a client, significant
other and occupational therapist and/or other team
members early in hospitalisation and before discharge.
The DPAT includes two rating scales of confidence (client
and family member), and captures subscales related to
returning home and managing care (including mobility
in the home, mobility in the community, bathroom,
bedroom, kitchen, household management, medication
management, nutrition and diet, skin management and
leisure). Results of the predischarge confidence and
discharge plan evaluation (for participants in each group)
will be shared with the inpatient rehabilitation team prior
to discharge. The family-led home environment assessment is a standardised checklist that is completed by the
family, who are also loaned a tablet computer or digital
camera to take photos of areas of the home that the
participant would need or wish to access on return home.
Using digital photographs taken by family members,
patient information and an equipment list has previously
been shown to be an accurate method of collecting necessary information for occupational therapy home modifications/equipment prescriptions.21 22
In addition, participants will receive written instructions outlining their recommended home modifications
and education for use of prescribed equipment prior to
discharge.
Participants in the experimental group will then
receive the HOME programme immediately following
the standardised discharge planning intervention. Previously tested in an older, acute population,15 23 and piloted
in general rehabilitation,16 the HOME programme is
centred in the occupational therapy understanding that
the interactions between a person and their environment

drive meaningful participation in activity after hospitalisation.24–26 The HOME programme commences during
hospitalisation and dovetails with the standardised
discharge planning intervention, but unlike the control
intervention, the HOME programme continues posthospitalisation (box 1). During hospitalisation, there is a focus
on safety and transition from hospital, while posthospitalisation, the focus is on increasing a person’s capacity to
deal with demands from the environment and their newly
acquired disability to maximise independence.
The experimental group will receive one predischarge
(approximately 90 min) and two postdischarge visits by
an occupational therapist, followed by two booster telephone support sessions. Although performance gaps
addressed are participant-specific (tailored), the process
to identify and address the issues limiting independence
and return to activity will be systematic and reproducible
across all participants in the experimental group. Thus,
all participants will receive identical intervention components. While still in hospital, a predischarge home assessment is conducted to assess the person-environment fit as
well as observe the use of prescribed equipment in situ.
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Using the I-HOPE, activities that are valued but difficult
to perform in the home environment will be identified
and then prioritised, and the magnitude of the influence
of the environment on performance of these activities
will be assessed by the occupational therapist.27 Participation goals will then be set and results were shared with
the inpatient rehabilitation team. These same I-HOPE
goals will then shape the two postdischarge occupational
therapy sessions with the aim of enhancing self-efficacy
beliefs and promoting independence and the sense of
control through mastery of meaningful activities. The
two booster telephone support sessions will reinforce goal
performance, enhance intrinsic motivation to return to
activity28 and facilitate effective communication between
the participant, family/carers and GP.29
Participants in the control group will receive only the
standardised discharge planning intervention. Contamination from the experimental intervention will be determined by examining the resource diary at the end of
4-week intervention period, specifically to identify occupational goals and interventions.
Primary outcome
Activity participation will be measured using the
Nottingham Extended Activities of Daily Living
(NEADL).30 The NEADL is a self-reported measure of
22 activities representing four domains of daily living
(mobility, kitchen, domestic and leisure) considered
to be important to people with stroke who have been
discharged home.

from linkages with the National Death Index held by the
Australian Institute of Health and Welfare, including
those who may be lost to follow-up at 6 months and 12
months.
Economic evaluation
Direct costs for delivering each intervention over and
above standard care (staff time and transportation,
consumables and equipment), participant-related direct
and indirect costs (participant time and transportation,
change in employment status and impact of the intervention on the activities of carers) and health system costs
(ie, costs of health services used, readmissions) will be
collected at each assessment time point and at 12 months.
Hospital admissions (inclusive of emergency presentations and hospital admissions) will be collected from two
sources at all timepoints, self-report by the participant
and data obtained from hospital administrative data
sets. Cost of each treatment pathway, resources used and
their costs will be collected. Self-reported data related
to health service utilisation and medications will be
confirmed through person-level linkages of participant
data with data held by state and commonwealth health
departments. This will include the Pharmaceutical Benefits Scheme and Medicare Benefits Schedule for the 12
month period following discharge and a 12 month period
prior to the index stroke event (to permit adjustment for
prestroke utilisation trends that may be unrelated to the
interventions being studied or unbalanced between the
groups).
Data monitoring
Data safety and monitoring will be overseen by two health
professionals and one statistician independent of the
trial. The committee will review data related to safety and
trial conduct within 3 months of enrolment of the first
participant and then annually; an interim analysis will be
undertaken at n=240. The committee will be responsible
for stopping recruitment in the case of multiple serious,
trial-related adverse events. For the purposes of this study,
a serious adverse event will be defined as an event that
(1) is fatal or life threatening, (2) results in persistent or
significant disability or (3) results in hospitalisation. A
nonserious adverse event would include such undesirable
experiences such as noninjurious fall.

Secondary outcomes
Quality of the care transition that is associated with
hospitalisation will be assessed using the 3-item Care
Transitions Measure,31 which is a validated measure
reflecting the quality of a person’s care transition that
is associated with hospital utilisation.
►► Disability will be assessed by administering the
mRS.32 33
►► Functional ability will be assessed using the Functional
Autonomy Measurement System,34 which measures in
five areas: activities of daily living, mobility, communication, mental functions and instrumental activities of
daily living.
►► Health-related quality of life will be assessed using the
EQ-5D-5L35 and will be used to also estimate quality-
adjusted life years for the economic evaluation.
►► Carer burden will be assessed using the Carer Experience Scale (CES).36 The CES focuses on six domains:
activities outside caring, support from family and
friends, assistance from the government and other
organisations, fulfilment from caring, control over
caring and getting on with the care recipient; this
measure is administered to the carer.
Descriptive information will include demographic and
socioeconomic information, details of the index stroke
and prior health-related resource use (including occupational therapy). Date and cause of death will be obtained

Patient and public involvement
Principles of the National Health and Medical Research
Council Consumer and Community Involvement in
Health and Medical Research statement37 have informed
our approach to consumer and public engagement, with
collaborative engagement with people with stroke, clinicians and policymakers from trial inception and design,
to conduct and dissemination. This trial is supported by
an end-user advisory panel, inclusive of advisors living
with stroke, carers, occupational therapists, health
managers and policymakers, who meet on a regular basis
throughout the study. We will consult this panel to voice
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end-user concerns, review process evaluation data and
to identify end-user-oriented solutions to any concerns;
multiple opportunities for involvement and feedback will
be made available during the analyses around emergent
concepts and trial implications to ensure engagement
through to dissemination. Trial results will be interpreted
by the end-user advisory panel, before a summary will be
shared with participants who have indicated this to be
their preference. All advisory panel members are paid an
honorarium and will be thanked in the contributorship
statement of any publications.
Process evaluation
The process evaluation plan was informed by the Medical
Research Council Guidance on Process Evaluations of
complex interventions38 and will focus on the evaluation
of fidelity and implementation context. Intervention
fidelity will be monitored throughout the study through
annual site review with participating therapists to ensure
that key components of the intervention are delivered,
adherence to the protocol, and completeness of outcome
assessments is maintained throughout the trial. Implementation will be explored using the RE-AIM (Reach,
Effectiveness, Adoption, Implementation, and Maintenance) framework39 components of Reach (measures of
participant participation and representativeness) with
collection of both quantitative and qualitative data to
provide insights into the acceptance and burden from the
perspectives of both participants and their carers; effectiveness (success rate at an individual level); adoption
(programme acceptance/uptake across the trial); implementation (fidelity of the programme to the protocolised
intervention and factors which may potentially affect the
trial outcome) and maintenance (long-
term effects at
the individual and organisational level) to both support
explanation of trial findings and inform scale-up should
the programme be effective.
Sample size estimates
Our pilot data demonstrated a mean change at 90 days
postdischarge of 2.7 (SD 5.5) in activity participation
measured by the NEADL in the home visit group and 0.8
(0.5) in the control group. For the purposes of power
analysis, we have hypothesised a potentially smaller but
still clinically important effect, where the control group
would exhibit a change score of 1 and a common SD of
5.5. Recruitment of a total of n=330 (equally distributed
between groups) would yield 80% power to detect such
an effect using independent t-test with two-tailed alpha
of 0.05. Allowing for potential attrition, the final total
sample size of n=360 is adopted for this study. This sample
size estimation is conservative, as in addition to the
smaller hypothesised effect size, we would also expect an
additional increase in power due to the inclusion of the
baseline NEADL scores as a covariate in a corresponding
analysis of covariance (ANCOVA) model prespecified for
the primary analysis.
Lannin NA, et al. BMJ Open 2021;11:e044573. doi:10.1136/bmjopen-2020-044573

Once the outcomes for n=240 participants are
obtained, an adaptive sample size estimation procedure
will be undertaken as per the ‘promising zone’ methodology Mehta and Pocock40 with a potential increase in
the total sample size to the prespecified maximum of 360
participants.
Statistical analyses
All randomised participants will be included in the analyses following intention-
to-
treat principles. Treatment
of missing data will be based on the satisfiability of missingness at random assumptions and will be based on the
intention-to-treat strategy as per White et al.41 Outcomes
will be analysed using appropriate analysis of covariance
or logistic regression models, controlling for baseline
values, and presented as mean between-group differences
(95% CI). For the primary outcome analysis, differences
in mean change in NEADL (baseline minus follow-up)
will be compared between groups using ANCOVA model
with change as an outcome, treatment group as a factor
and baseline value of NEADL as a covariate. The outcome
will be presented as mean between-group difference with
respective 95% CI. Effect of participant characteristics on
outcomes will be explored by including relevant interaction terms in regression models. The heterogeneity of
effect across sites will be tested using respective mixed-
effect models with individual centres as a random effect.
Similar adjusted analyses with appropriate regression
models will be conducted for continuous secondary
outcomes. Dichotomous secondary outcomes (ie, readmission) will be analysed using a logistic regression
model with the readmission as the dependent variable
and treatment group as independent variable, adjusted
for relevant prespecified covariates. The outcomes will
be presented as ORs with respective 95% CIs. Adjustment
covariates will be prespecified in a separate Statistical
Analysis Plan document that will provide the details of the
analysis strategy prior to the lock of the trial data.
For the economic evaluation, there will be a cost description analysis of each treatment pathway and the incremental difference for costs and quality-adjusted life years
determined. A full economic evaluation protocol will be
published prior to study recruitment being completed.
Study sponsorship and funding
The study is funded by the National Health and Medical
Research Council, Australia, grant ID 1141561). Trial
organisation, data management and monitoring are
supported by Monash University, Melbourne, Australia.

DISCUSSION
The HOME trial will provide information that will assist
survivors of stroke returning home after rehabilitation
and their families, rehabilitation clinicians and policymakers make more informed decisions about the benefits
of home assessments and postdischarge support for adults
early after stroke. Findings will lead to evidence-based
5
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clinical practise guideline recommendations, rather than
expert opinion, allowing for clearer health policy, which
in turn will improve outcomes for consumers and produce
greater cost-efficiency in the rehabilitation sector.
The HOME Trial is the first prospective, randomised
clinical trial to investigate the effect of adding an
enhanced occupational therapy discharge planning intervention that involves pre and postdischarge home visits,
goal setting and occupational therapy in the home to an
in-hospital predischarge planning intervention within a
rehabilitation setting. The trial has concealed allocation,
blinded assessment and intention-
to-
treat analysis and
includes a process evaluation and economic evaluation.
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